EP2443252
BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.6.2010:
29.11.2017:
10725045.8
:
14.6.2030
:
BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
15.6.2010
29.11.2017
:
Merck Patent GmbH:
Frankfurter Strasse 250, 64293, Darmstadt, DE
:
STROH, Christopher:
Dieburg, DE
:
VON HEYDEBRECK, Anja:
Darmstadt, DE
:
09008042:
19.6.2009:
EP
:
09012197:
25.9.2009:
EP
:
EP2010003563:
15.6.2010
:
C12Q 1/68, G01N 33/574